Table 3. Comparison of Posttreatment Prognoses for Biologic Therapy vs Traditional and Systemic Therapies.
| IGA score at baseline | Difference in transition probability, mean (95% CI) | |||||||
|---|---|---|---|---|---|---|---|---|
| 0-1 mo | 1-12 mo | |||||||
| IGA 0/1 | IGA 2 | IGA 3 | IGA 4 | IGA 0/1 | IGA 2 | IGA 3 | IGA 4 | |
| Biologic vs traditional therapy | ||||||||
| IGA 0/1 | −0.10 (−0.14 to −0.05) | 0.10 (0.06 to 0.14) | 0.02 (−0.01 to 0.05) | −0.02 (−0.03 to −0.01) | −0.20 (−0.26 to −0.14) | 0.20 (0.14 to 0.25) | 0.01 (−0.03 to 0.05) | −0.01 (−0.03 to 0.02) |
| IGA 2 | 0.00 (−0.02 to 0.02) | −0.05 (−0.07 to −0.02) | 0.04 (0.03 to 0.06) | 0.01 (0.00 to 0.01) | 0.03 (0.00 to 0.06) | −0.11 (−0.14 to −0.08) | 0.07 (0.04 to 0.09) | 0.02 (0.00 to 0.03) |
| IGA 3 | 0.08 (0.06 to 0.10) | 0.06 (0.04 to 0.08) | −0.15 (−0.17 to −0.13) | 0.01 (0.00 to 0.01) | 0.12 (0.09 to 0.14) | 0.09 (0.06 to 0.11) | −0.22 (−0.24 to −0.19) | 0.01 (0.00 to 0.02) |
| IGA 4 | 0.06 (0.02 to 0.09) | 0.06 (0.03 to 0.09) | 0.06 (0.05 to 0.08) | −0.18 (−0.22 to −0.14) | 0.08 (0.04 to 0.12) | 0.11 (0.07 to 0.15) | 0.02 (0.00 to 0.05) | −0.21 (−0.25 to −0.18) |
| Biologic vs systemic therapy | ||||||||
| IGA 0/1 | −0.12 (−0.17 to −0.07) | 0.15 (0.11 to 0.19) | 0.01 (−0.03 to 0.04) | −0.04 (−0.06 to −0.01) | −0.20 (−0.27 to −0.14) | 0.21 (0.16 to 0.27) | 0.00 (−0.05 to 0.05) | −0.01 (−0.04 to 0.02) |
| IGA 2 | −0.10 (−0.12 to −0.07) | 0.03 (0.01 to 0.06) | 0.05 (0.04 to 0.07) | 0.01 (0.00 to 0.02) | −0.05 (−0.08 to −0.02) | −0.04 (−0.07 to −0.01) | 0.06 (0.04 to 0.09) | 0.03 (0.01 to 0.04) |
| IGA 3 | 0.06 (0.04 to 0.08) | 0.04 (0.02 to 0.06) | −0.11 (−0.14 to −0.09) | 0.01 (0.00 to 0.02) | 0.09 (0.07 to 0.12) | 0.04 (0.02 to 0.07) | −0.15 (−0.17 to −0.12) | 0.01 (0.00 to 0.02) |
| IGA 4 | 0.06 (0.03 to 0.09) | 0.08 (0.06 to 0.11) | 0.04 (0.02 to 0.06) | −0.19 (−0.23 to −0.15) | 0.11 (0.07 to 0.14) | 0.08 (0.04 to 0.11) | 0.01 (−0.02 to 0.03) | −0.19 (−0.23 to −0.16) |
Abbreviation: IGA, Investigator’s Global Assessment.